DermaClose DUKE Fasciotomy and Wound Study
DermaClose Continuous External Tissue Expander for the Management of Four-Compartment Fasciotomy and Full-Thickness Wounds.
Sponsor: Baxter Healthcare Corporation
Terminated
Slow enrollment
Other terminated trials from Baxter Healthcare Corporation
- Neuromuscular Diseases · Phase NA · Feb 2024
- Critical Illness · Phase NA · Aug 2022
- Acute Heart Failure · Oct 2021
- Atrial Fibrillation · Dec 2020
- Healthy Volunteers · Phase NA · Mar 2020
More terminations from Baxter Healthcare Corporation
Other Wound of Skin trials with similar outcome
A observational or N/A phase clinical study on Wound of Skin, this trial is terminated or withdrawn. The trial is conducted by Baxter Healthcare Corporation and has accumulated 10 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Apr 2025 — Present [monthly]
Terminated
Status: Unknown → Terminated
-
Mar 2025 — Apr 2025 [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Mar 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Mar 2023 — Jul 2024 [monthly]
Recruiting
▶ Show 5 earlier versions
-
Feb 2023 — Mar 2023 [monthly]
Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Recruiting
-
Sep 2022 — Dec 2022 [monthly]
Recruiting
-
Jun 2022 — Sep 2022 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
May 2022 — Jun 2022 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Baxter Healthcare Corporation
- Duke University
For direct contact, visit the study record on ClinicalTrials.gov .